The potential of hybrid antibodies secreted by hybrid-hybridomas in tumour therapy
- 1 January 1988
- journal article
- Published by Wiley in International Journal of Cancer
- Vol. 41 (S2) , 15-17
- https://doi.org/10.1002/ijc.2910410706
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- The use of hybrid hybridomas to target human cytotoxic T lymphocytesEuropean Journal of Immunology, 1987
- Hybrid hybridoma producing a bispecific monoclonal antibody that can focus effector T-cell activity.Proceedings of the National Academy of Sciences, 1986
- Heteroantibody duplexes target cells for lysis by cytotoxic T lymphocytes.Proceedings of the National Academy of Sciences, 1985
- Specific targeting of cytotoxic T cells by anti-T3 linked to anti-target cell antibodyNature, 1985
- Hybrid antibodies can target sites for attack by T cellsNature, 1985
- Cytotoxic T lymphocyte-mediated lysis via the Fc receptor of target cellsEuropean Journal of Immunology, 1985
- Attachment of an anti-receptor antibody to non-target cells renders them susceptible to lysis by a clone of cytotoxic T lymphocytes.Proceedings of the National Academy of Sciences, 1984
- Hybrid hybridomas and their use in immunohistochemistryNature, 1983
- Fusion of Two Immunoglobulin-producing Myeloma CellsNature, 1973